[HTML][HTML] The pathogenesis of coronavirus-19 disease
AC Borczuk, RK Yantiss - Journal of biomedical science, 2022 - Springer
Severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) is the causal
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
[HTML][HTML] Pulmonary and extra-pulmonary clinical manifestations of COVID-19
KD Johnson, C Harris, JK Cain, C Hummer… - Frontiers in …, 2020 - frontiersin.org
The severe acute respiratory syndrome coronavirus− 2 (SARS-CoV-2) has been recently
identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 …
identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 …
Profiling post-COVID syndrome across different variants of SARS-CoV-2
Background Self-reported symptom studies rapidly increased our understanding of SARS-
CoV-2 during the pandemic and enabled the monitoring of long-term effects of COVID-19 …
CoV-2 during the pandemic and enabled the monitoring of long-term effects of COVID-19 …
[HTML][HTML] Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
I Thevarajan, THO Nguyen, M Koutsakos, J Druce… - Nature medicine, 2020 - nature.com
To the Editor—We report the kinetics of immune responses in relation to clinical and
virological features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) …
virological features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) …
[HTML][HTML] COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
[HTML][HTML] COVID-19 post-acute sequelae among adults: 12 month mortality risk
AG Mainous III, BJ Rooks, V Wu, FA Orlando - Frontiers in medicine, 2021 - frontiersin.org
Background: There are concerns of post-acute sequelae of COVID-19, but it is unclear
whether COVID-19 poses a significant downstream mortality risk. The objective was to …
whether COVID-19 poses a significant downstream mortality risk. The objective was to …
[PDF][PDF] COVID-19 and its long-term sequelae: what do we know in 2023
Post‑viral syndrome is a well‑known medical condition characterized by different levels of
physical, cogni‑tive, and emotional impairment that may persist with fluctuating severity after …
physical, cogni‑tive, and emotional impairment that may persist with fluctuating severity after …
[HTML][HTML] An early warning system for emerging SARS-CoV-2 variants
An early warning system for emerging SARS-CoV-2 variants | Nature Medicine Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …
content Thank you for visiting nature.com. You are using a browser version with limited support …
Diagnosis and Management of Complications of COVID-19
Long-term complications are frequent in recovering COVID-19 cases. However, long-term
complications of COVID-19 are currently unclear. If similar rate of long-term complications …
complications of COVID-19 are currently unclear. If similar rate of long-term complications …
COVID-19 pathogenesis and clinical manifestations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the
Betacoronavirus genus (which also includes SARS 1 and Middle East respiratory syndrome …
Betacoronavirus genus (which also includes SARS 1 and Middle East respiratory syndrome …